These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 15915241

  • 1. [Resistance to penicillin and erythromycin of Streptococcus pneumoniae and Streptococcus pyogenes isolated from community-acquired respiratory infections in Spain between 1986-1999 and its relationship with the use of beta-lactams and macrolides].
    Granizo Martínez JJ.
    Rev Esp Quimioter; 2005 Mar; 18(1):83-5. PubMed ID: 15915241
    [No Abstract] [Full Text] [Related]

  • 2. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J, Fernandes ML, Serrano N, Grupo de Estudo Português de Bactérias Patogénicas Respiratórias.
    Acta Med Port; 2001 Mar; 14(5-6):459-68. PubMed ID: 11878155
    [Abstract] [Full Text] [Related]

  • 3. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP, Zhanel GG.
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [Abstract] [Full Text] [Related]

  • 4. Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital.
    Bonofiglio L, Ojeda MI, de Mier C, Vay C, Famiglietti A, Gutkind G, Mollerach M.
    Int J Antimicrob Agents; 2005 Mar; 25(3):260-3. PubMed ID: 15737523
    [Abstract] [Full Text] [Related]

  • 5. [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
    Gordillo RM, Lacasa MJ, Ibarra A, Rodríguez F, Casal M.
    Rev Esp Quimioter; 2003 Mar; 16(1):58-60. PubMed ID: 12750758
    [Abstract] [Full Text] [Related]

  • 6. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN, Sader HS, Stilwell MG, Fritsche TR.
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [Abstract] [Full Text] [Related]

  • 7. Meta-analysis of bacterial resistance to macrolides.
    Halpern MT, Schmier JK, Snyder LM, Asche C, Sarocco PW, Lavin B, Nieman R, Mandell LA.
    J Antimicrob Chemother; 2005 May; 55(5):748-57. PubMed ID: 15772147
    [Abstract] [Full Text] [Related]

  • 8. [Erythromycin resistance of group A beta-hemolytic streptococci isolated from patients with upper respiratory tract infections].
    Yazgi H, Ertek M, Aktaş AE.
    Mikrobiyol Bul; 2002 Jan; 36(1):11-4. PubMed ID: 12476761
    [Abstract] [Full Text] [Related]

  • 9. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.
    Bergman M, Huikko S, Pihlajamäki M, Laippala P, Palva E, Huovinen P, Seppälä H, Finnish Study Group for Antimicrobial Resistance (FiRe Network).
    Clin Infect Dis; 2004 May 01; 38(9):1251-6. PubMed ID: 15127336
    [Abstract] [Full Text] [Related]

  • 10. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors.
    Aspa J, Rajas O, Rodríguez de Castro F, Blanquer J, Zalacain R, Fenoll A, de Celis R, Vargas A, Rodríguez Salvanés F, España PP, Rello J, Torres A, Pneumococcal Pneumonia in Spain Study Group.
    Clin Infect Dis; 2004 Mar 15; 38(6):787-98. PubMed ID: 14999620
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN, Fritsche TR, Sader HS.
    Diagn Microbiol Infect Dis; 2005 Jun 15; 52(2):129-33. PubMed ID: 15964501
    [Abstract] [Full Text] [Related]

  • 13. [Antibiotic resistance of Streptococcus pneumoniae and Streptococcus pyogenes in 1996-2009].
    Urbásková P, Zemlicková H, Pracovní skupina pro monitorování rezistence (PSMR).
    Epidemiol Mikrobiol Imunol; 2011 Feb 15; 60(1):10-20. PubMed ID: 21542231
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
    Rodríguez-Zurita ME, Solís del Baño S, Robres Guillén P, González Praetorius A, Gimeno Fernández C, Pérez Pomata MT, Bisquert Santiago J.
    Rev Esp Quimioter; 2003 Mar 15; 16(1):61-4. PubMed ID: 12750759
    [Abstract] [Full Text] [Related]

  • 16. [Correlation between antibiotic prescription and decreased antimicrobial resistance in the health area of Zamora].
    Díaz A, Ochoa C, Brezmes MF, López-Urrutia L, Rivas N.
    Enferm Infecc Microbiol Clin; 2009 Mar 15; 27(3):153-9. PubMed ID: 19306715
    [Abstract] [Full Text] [Related]

  • 17. [Bacteriology of cutaneous infections of the child].
    Raymond J, Cohen R.
    Arch Pediatr; 2008 Oct 15; 15 Suppl 2():S59-61. PubMed ID: 19000856
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
    Gattringer R, Sauermann R, Lagler H, Stich K, Buxbaum A, Graninger W, Georgopoulos A.
    Int J Antimicrob Agents; 2004 Sep 15; 24(3):290-3. PubMed ID: 15325435
    [Abstract] [Full Text] [Related]

  • 19. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
    Rothermel CD.
    Clin Infect Dis; 2004 May 15; 38 Suppl 4():S346-9. PubMed ID: 15127368
    [Abstract] [Full Text] [Related]

  • 20. Short-course beta-lactam treatment for community-acquired pneumonia.
    Stralin K, Sjöberg L, Holmberg H.
    Clin Infect Dis; 2004 Mar 01; 38(5):766-7. PubMed ID: 14986269
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.